Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $24,913 | $51,235 | $52,258 | $62,257 |
| - Cash | $5,050 | $6,205 | $16,167 | $23,798 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $19,863 | $45,029 | $36,090 | $38,458 |
| Revenue | $1,885 | $2,316 | $1,654 | $7,770 |
| % Growth | -18.6% | 40% | -78.7% | – |
| Gross Profit | $1,885 | $2,035 | $1,374 | $7,490 |
| % Margin | 100% | 87.9% | 83.1% | 96.4% |
| EBITDA | -$9,328 | -$9,950 | -$16,263 | -$13,558 |
| % Margin | -494.8% | -429.7% | -983% | -174.5% |
| Net Income | -$9,391 | -$9,745 | -$14,277 | -$5,445 |
| % Margin | -498.1% | -420.8% | -863% | -70.1% |
| EPS Diluted | -0.046 | -0.054 | -0.098 | -0.038 |
| % Growth | 15.5% | 44.9% | -158.9% | – |
| Operating Cash Flow | -$8,720 | -$9,961 | -$14,283 | -$3,298 |
| Capital Expenditures | -$50 | $0 | $0 | $0 |
| Free Cash Flow | -$8,770 | -$9,961 | -$14,283 | -$3,298 |